)
Visual
earnings real time
Ocular Therapeutix (OCUL) investor relations material
Ocular Therapeutix Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Piper Sandler 37th Annual Healthcare Conference summary3 Dec, 2025
Company overview and clinical focus
Focuses on retina diseases with two phase III studies, SOL-1 and SOL-R, targeting VEGF using a tunable hydrogel platform.
SOL-1 readout expected in Q1 2026; SOL-R in the first half of 2027.
Aims to address sustainability and long-term outcomes in retinal disease treatment.
Seeks to improve patient adherence and outcomes by providing sustained VEGF suppression.
Clinical trial design and objectives
SOL-1 is designed for a superiority label in wet macular degeneration, validated by FDA SPA.
SOL-R focuses on clinical relevance and non-inferiority, with both trials required for approval.
SOL-1 provides data on drug durability and repeatability; SOL-R compares against standard and high-dose EYLEA.
Numeric analysis versus high-dose EYLEA offers commercial leverage.
SOL-X open-label extension will provide long-term data, especially for crossover patients.
Target product profile and adoption
Targeting a triad: superiority label, large market size, and high adoptability.
Superiority label enables clinicians to choose the drug from day one, bypassing step therapy.
Seamless adoption expected due to similar administration experience as current anti-VEGFs.
Durability goal is nine to ten months, aligning with six-month patient visits.
How does SOLAR's design mitigate regulatory risk?
How does AXPAXLI address NPDR market barriers?
How does SOLEX data support long-term value?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Ocular Therapeutix earnings date
Q4 20256 Mar, 2026
Next Ocular Therapeutix earnings date
Q4 20256 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Ocular Therapeutix Inc is a biopharmaceutical company focused on the development and commercialization of therapies for diseases and conditions of the eye. The company specializes in proprietary hydrogel-based drug delivery platforms designed for ophthalmology treatments. Ocular Therapeutix serves the healthcare sector by addressing needs in areas such as post-surgical inflammation, dry eye disease, and retinal diseases. The company is headquartered in Bedford, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage